[May 23, 2012] 36.7% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB) Tweet May 23, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on September 14th, 2011 at $96.76. In approximately 8 months, Biogen Idec has returned 36.73% as of today's recent price of $132.29. Over the past year, Biogen Idec has traded in a range of $83.83 to $138.50 and is now at $132.29, 58% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 0.5%. Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Biogen Idec shares.Log in and add Biogen Idec (BIIB) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]